Offerings // Jade Biosciences, Inc.

JBIO offering history

Every offering-related filing in Jade Biosciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 509 filings back to Jan 8, 2020.

Last executed offering

Jun 4, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

May 7, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jun 4, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 3, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 15, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 15, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 15, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 7, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 7, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 7, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 7, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 6, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 6, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 30, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 30, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 22, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Dec 19, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 19, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 15, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 14, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 7, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 25, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 25, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 25, 2024	RW →	WITHDRAWN	Registration withdrawn
Oct 31, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 10, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 5, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 23, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 15, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 30, 2021	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 29, 2021	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Jun 29, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 25, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 24, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 17, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 9, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

JBIO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full JBIO workspace →

JBIO offering FAQ

When did JBIO last execute an offering?

Per SEC filings, Jade Biosciences, Inc.'s most recent priced offering document is a 424B5 filed 2026-06-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did JBIO last announce or register an offering?

The most recent registration is a S-3 filed 2026-05-07. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.